Emergence of fluoroquinolone resistance in Neisseria gonorrhoeae isolates from four clinics in three regions of Kenya.

Journal article

We have recently reported high levels of fluoroquinolone resistance in a single region of Kenya. In this article, we report high prevalence of fluoroquinolone resistance (53.2%) in Neisseria gonorrhoeae isolates from 4 clinics in 3 additional regions of Kenya. These findings highlight the need to change first-line treatment in these settings and the need to evaluate empirical management guidelines for treatment of gonococcal infection in Kenya.

Authors: Lagace-Wiens, P; Duncan, S; Kimani, J; Thiong'o, A; Shafi, J

• Publication status: Published
• Journal: Sexually transmitted diseases
• Volume: 39
• Issue: 5
• Pages: 332-334
• Publication date: 2012-05-01
• DOI: 10.1097/olq.0b013e318248a85f
• EISSN: 1537-4521
• ISSN: 0148-5717
• Language: English
• Keywords: Drug Resistance, Bacterial; Female; Sentinel Surveillance; Adult; Mass Screening; Prevalence; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Male; Fluoroquinolones; Kenya